$16.9 Billion is the total value of FARALLON CAPITAL MANAGEMENT LLC's 102 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PLYA | PLAYA HOTELS & RESORTS NV | $294,745,000 | -10.8% | 30,606,930 | 0.0% | 1.74% | -14.7% | |
| ANTM | ANTHEM INC | $283,642,000 | +15.1% | 1,035,000 | 0.0% | 1.68% | +10.1% | |
| ASND | ASCENDIS PHARMA A Ssponsored adr | $103,264,000 | +6.5% | 1,457,297 | 0.0% | 0.61% | +1.8% | |
| SAGE | SAGE THERAPEUTICS INC | $88,281,000 | -9.8% | 625,000 | 0.0% | 0.52% | -13.7% | |
| ZEAL | ZEALAND PHARMA A Ssponsored adr | $14,868,000 | +30.3% | 900,000 | 0.0% | 0.09% | +25.7% | |
| CCXI | CHEMOCENTRYX INC | $14,536,000 | -4.0% | 1,150,000 | 0.0% | 0.09% | -8.5% | |
| VOYA | VOYA FINL INC | $9,189,000 | +5.7% | 185,000 | 0.0% | 0.05% | 0.0% | |
| GCVRZ | SANOFIright 12/31/2020 | $3,823,000 | +12.0% | 6,827,805 | 0.0% | 0.02% | +9.5% | |
| PFNX | PFENEX INC | $3,066,000 | -5.5% | 600,000 | 0.0% | 0.02% | -10.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 44 | Q2 2024 | 3.7% |
| ALPHABET INC | 35 | Q2 2024 | 4.2% |
| GRIFOLS S A | 35 | Q2 2024 | 0.9% |
| SPDR S&P 500 ETF TR | 34 | Q2 2024 | 27.6% |
| VISA INC | 33 | Q2 2024 | 2.9% |
| RADIUS HEALTH INC | 33 | Q2 2022 | 1.7% |
| WABTEC CORP | 30 | Q2 2024 | 3.6% |
| EXELIXIS INC | 30 | Q2 2024 | 3.0% |
| SAVARA INC | 29 | Q2 2024 | 0.3% |
| TRANSUNION | 28 | Q2 2024 | 3.7% |
View FARALLON CAPITAL MANAGEMENT LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Marblegate Acquisition Corp. | February 01, 2024 | 150,000 | 2.6% |
| Clever Leaves Holdings Inc. | January 23, 2024 | ? | ? |
| SDCL EDGE Acquisition Corp | January 23, 2024 | ? | ? |
| Atento S.A. | March 15, 2023 | 2,230,357 | 15.4% |
| Metals Acquisition Corp | February 07, 2023 | 2,489,700 | 9.4% |
| Inflection Point Acquisition Corp. | February 06, 2023 | 1,900,000 | 5.8% |
| AMYRIS, INC. | February 24, 2022 | 1,068,904 | 0.3% |
| Swiftmerge Acquisition Corp. | February 14, 2022 | 291,060 | 1.3% |
| Caribou Biosciences, Inc. | February 11, 2022 | 2,428,150 | 4.0% |
| ENANTA PHARMACEUTICALS INC | February 11, 2022 | 287,000 | 1.4% |
View FARALLON CAPITAL MANAGEMENT LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-09-03 |
| 13F-HR/A | 2024-08-14 |
| 13F-HR | 2024-08-14 |
| 13F-HR/A | 2024-05-24 |
| 13F-HR/A | 2024-05-15 |
| 13F-HR/A | 2024-05-15 |
| 13F-HR | 2024-05-15 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
View FARALLON CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.